Verapamil with antibiotics for resistant infections in cancer patients
Treatments studied
Part of Cancer, Infections clinical trials.
This study looks at whether a common heart medication (verapamil) can help antibiotics work better against resistant bacteria in cancer patients. If you have a resistant infection, it might offer new ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under care for cancer.
- You have an infection caused by bacteria.
- The bacteria are resistant to at least three classes of antibiotics (multi-drug resistant or worse).
- Your sample was sent to the Assiut University laboratory for testing.
- Samples from non-cancer patients, contaminants, or repeated identical samples are not included.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a combination antibiotic called aztreonam-avibactam for treating infections caused by hard-to-treat bacteria, especially those that produce certain enzymes (MBLs). It aims to see how well this medicine works in hospital patients.
This study tests which of two antibiotic combinations works better at clearing infections caused by multi-drug-resistant bacteria in adults, including those with weakened immune systems. It aims to find a more effective treatment option.
This study looks at how a certain antibiotic (ceftazidime-avibactam) works in people with blood cancers or stem cell transplants, and how the drug levels affect the bacteria. It aims to find the best dosing to fight infections and reduce resistance.
This study tests a new antibiotic called oritavancin for treating skin infections at the site of heart devices like pacemakers or defibrillators, especially when caused by drug-resistant bacteria. The goal is to see if this once-daily antibiotic works as well as the standard treatment.
This study tests whether giving antibiotics chosen specifically for your resistant bacteria before a liver transplant can prevent infections better than the usual standard antibiotics. It aims to improve recovery and lower the risk of serious infection after surgery.
This trial looks at how well two antibiotics, ceftazidime-avibactam and fosfomycin, work together to treat infections caused by highly resistant bacteria called CRE. It may help find the best way to use these medicines.
Hear when a new Antibiotic Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.